Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05512013 · ClinicalTrials.gov registry record · Phase 1
The Effects of NSAIDs on Bone Metabolism Following Exercise
A Phase 1 study, sponsored by United States Army Research Institute of Environmental Medicine.
- Completed
- Registry status
- Phase 1
- Development phase
- 12
- Enrollment target
NCT05512013 is a Phase 1 study that has completed, run by United States Army Research Institute of Environmental Medicine. The registered enrollment target is 12 participants.
The verdict
NCT05512013, a Phase 1 study, has completed, sponsored by United States Army Research Institute of Environmental Medicine.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 12 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the effects of a single dose of non-steroidal anti-inflammatory drugs on post-exercise markers of bone and muscle metabolism.
Interventions
- DRUG Placebo
- DRUG Ibuprofen 800 mg
- DRUG Celecoxib 200mg
- DRUG Flurbiprofen 100 mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2022-02-15 |
| Est. Completion | 2023-04-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05512013
The ClinicalTrials.gov registry entry for NCT05512013 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is United States Army Research Institute of Environmental Medicine, which has 59 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT05512013 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05512013 about?
NCT05512013 is a clinical study titled "The Effects of NSAIDs on Bone Metabolism Following Exercise". The purpose of this study is to determine the effects of a single dose of non-steroidal anti-inflammatory drugs on post-exercise markers of bone and muscle metabolism.
What is the current status of trial NCT05512013?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 12 participants. The study started on 2022-02-15. Estimated completion is 2023-04-01.
What interventions are being tested in trial NCT05512013?
The interventions under investigation include: Placebo (DRUG), Ibuprofen 800 mg (DRUG), Celecoxib 200mg (DRUG), Flurbiprofen 100 mg (DRUG).
Who is sponsoring clinical trial NCT05512013?
This trial is sponsored by United States Army Research Institute of Environmental Medicine, which has 59 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.